CBUS
Cibus, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.19
+4.38%Nov 3, 2026, 21:05 UTC
Cibus announced that it will report its third-quarter 2026 financial results on November 12, 2026, after the market close, and host a conference call and webcast at 4:30 p.m. ET.
Source:Sep 28, 2026, 20:05 UTC
Cibus and Crystal Crop Protection announced a collaboration to improve mustard crop varieties in India using Cibus' gene-editing platform and Crystal Crop's mustard germplasm and distribution reach.
Source:Aug 13, 2026, 20:05 UTC
Cibus, Inc. announced its financial results for the quarter ended June 30, 2026, reporting a 19% sequential and 31% year-over-year decline in quarterly net cash usage.
Jun 9, 2026, 00:00 UTC
Cibus, Inc. appointed Craig Wichner as Chief Executive Officer effective June 8, 2026.
Source: